Volumetric Modulated Arc Therapy of the Pelvic Lymph Nodes to the Aortic Bifurcation in Higher Risk Prostate Cancer: Early Toxicity Outcomes

Table 2

Dose, fractionation schedules, and treatment groups.

Treatment intent	Prescription dose	Number of fractions	Number of patients (%)
			No ADT	ADT	Total
Definitive VMAT
Intermediate risk	74 Gy	37	5	4	9
High risk	78 Gy	39	1	15	16
Total	—	—	6 (5%)	19 (17%)	25 (22%)
VMAT following HDR brachytherapy	50.4 Gy	28	9 (8%)	16 (14%)	25 (22%)
Salvage VMAT	66 Gy	33	38 (34%)	11 (10%)	49 (44%)
Adjuvant VMAT	66 Gy	33	9 (8%)	5 (4%)	14 (12%)
Total	—	—	62 (55%)	51 (45%)	113 (100%)